Stocks and InvestingStocks and Investing
Thu, December 8, 2022
Wed, December 7, 2022
Tue, December 6, 2022
Mon, December 5, 2022

Chris Shibutani Initiated (UTHR) at Strong Sell and Held Target at $230 on, Dec 5th, 2022


Published on 2024-10-28 00:26:29 - WOPRAI, Chris Shibutani
  Print publication without navigation


Chris Shibutani of Goldman Sachs, Initiated "United Therapeutics Corporation" (UTHR) at Strong Sell and Held Target at $230 on, Dec 5th, 2022.

Chris has made no other calls on UTHR in the last 4 months.



There are 4 other peers that have a rating on UTHR. Out of the 4 peers that are also analyzing UTHR, 0 agree with Chris's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Chris


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $300 on, Thursday, November 3rd, 2022
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $375 on, Thursday, November 3rd, 2022
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $265 on, Thursday, November 3rd, 2022
  • Terence Flynn of "Morgan Stanley" Maintained at Buy with Increased Target to $322 on, Thursday, November 3rd, 2022